Helius Medical Technologies, Inc. (HSDT) financial statements (2021 and earlier)

Company profile

Business Address 642 NEWTOWN YARDLEY ROAD
NEWTOWN, PA 18940
State of Incorp.
Fiscal Year End December 31
SIC 3845 - Electromedical and Electrotherapeutic Apparatus (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
3/31/2016
3/31/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments526631
Cash and cash equivalents526630
Short-term investments    0
Receivables10100
Inventory, net of allowances, customer advances and progress billings10   
Inventory10   
Prepaid expense10 10
Other current assets 0 0 
Other undisclosed current assets  0  
Total current assets:727741
Noncurrent Assets
Operating lease, right-of-use asset1
Property, plant and equipment110  
Long-term investments and receivables 0   
Accounts and financing receivable, after allowance for credit loss 0   
Intangible assets, net (including goodwill)2    
Goodwill1    
Intangible assets, net (excluding goodwill)1    
Other noncurrent assets000  
Total noncurrent assets:310  
TOTAL ASSETS:1028741
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:34521
Accounts payable223  
Accrued liabilities221  
Other undisclosed accounts payable and accrued liabilities   21
Deferred revenue0
Debt0    
Derivative instruments and hedges, liabilities01410  
Other undisclosed current liabilities   0 
Total current liabilities:4181421
Noncurrent Liabilities
Long-term debt and lease obligation0    
Operating lease, liability0
Liabilities, other than long-term debt0  22
Deferred revenue0
Derivative instruments and hedges, liabilities   22
Total noncurrent liabilities:1  22
Total liabilities:5181443
Stockholders' equity
Stockholders' equity attributable to parent610(7)(0)(2)
Common stock00522416
Common stock, value, subscriptions    0
Additional paid in capital111105732
Accumulated other comprehensive income (loss)(1)(1)0(1)(1)
Accumulated deficit(105)(95)(66)(26)(19)
Total stockholders' equity:610(7)(0)(2)
TOTAL LIABILITIES AND EQUITY:1028741

Income statement (P&L) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
3/31/2016
3/31/2015
Revenues10   
Cost of revenue
(Cost of Goods and Services Sold)
(1)    
Other undisclosed gross profit1    
Gross profit:10   
Operating expenses(25)(27)(23)(9)(7)
Other undisclosed operating loss    (3)
Operating loss:(24)(27)(23)(9)(10)
Nonoperating income (expense)14(2)(5)2(0)
Foreign currency transaction gain (loss), before tax 1(2)(0)1
Interest and debt expense   0(0)
Loss from continuing operations before equity method investments, income taxes:(10)(29)(28)(7)(10)
Other undisclosed income from continuing operations before income taxes205756  
Net income (loss):102928(7)(10)
Other undisclosed net income (loss) attributable to parent(20)(57)(56)(0)0
Net loss available to common stockholders, diluted:(10)(29)(28)(7)(10)

Comprehensive Income ($ in millions)

12/31/2019
12/31/2018
12/31/2017
3/31/2016
3/31/2015
Net income (loss):102928(7)(10)
Comprehensive income (loss):102928(7)(10)
Other undisclosed comprehensive loss, net of tax, attributable to parent(20)(58)(54)(0)(1)
Comprehensive loss, net of tax, attributable to parent:(10)(29)(26)(7)(11)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: